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Muscle and diet-induced thermogenesisThe recent characterization of brown fat in humans has generated much excitement on the possibility that
increased energy expenditure by heat production by this tissue will be able to reduce obesity. This expectation
has largely been stimulated by studies with mice that show strong associations between increased brown fat
activity and reductions in obesity and insulin resistance. Research in the mouse has been largely based upon
the induction or suppression of brown fat andmitochondrial uncoupling protein by geneticmethods. The review
of this research literature underscores the idea that reductions in obesity in mice are secondary to the primary
role of brown adipose tissue in the regulation of body temperature. Given that the variation in brown
fat in humans, as detected by PET imaging, is highly associated with administration of adrenergic agonists and
reductions in ambient temperature, the effects on obesity in humans may also be secondary to the regulation
of body temperature. Induction of thermogenesis by reduced ambient temperature now becomes like muscle
and physical activity, another natural method of increased energy expenditure to combat obesity. Furthermore,
there is no evidence to indicate that heat production by adrenergic stimulation via cold exposure or drug
treatment or the enriched physical environment is restricted to the thermogenic activity of the brown adipocyte.
This article is part of a Special Issue entitled: Modulation of Adipose Tissue in Health and Disease.
© 2013 Elsevier B.V. All rights reserved.1. Introduction and overview
From genetic, molecular and physiological studies on brown fat
(BAT-brown adipose tissue) and the regulation of body weight a
strong case can be made to support the idea that activation and/or
induction of BAT can provide an effective treatment to reduce obesity.
Most of the thinking and experimental effort to realize this therapy
is currently directed towards elucidating the cellular signaling and
transcription pathways controlling induction of BAT/thermogenesis.
It is anticipated that key regulatory steps in the process will become
drug targets to stimulate thermogenesis and reduce obesity. However,
given that induction of brown adipocytes is a developmental problem
involving genes that are more broadly involved in development
than just induction of brown adipocytes, the synthesis of safe drugs
will probably be a slow long-term process. Consequently, an alternative
strategy is necessary to deﬁne the environmental conditions, including
diet, exercise and ambient temperature, from birth to adulthood
that will maximize thermogenesis and achieve the same result in a
drug-free manner. The extent to which we are successful in identifying
the environmental conditions that can induce nonshivering thermogen-
esis (NST), themore successful wewill be inminimizing pharmaceuticalion of Adipose Tissue in Health
l rights reserved.options based upon targeting transcription and signaling factors of
brown adipogenesis, or transplanting genetically engineered cells and
tissues with thermogenic activity. Additionally, inducible nonshivering
thermogenesis is not just a function of BAT-mediated thermogenesis,
rather increasing evidence suggests that NST can also be provided by
skeletal muscle, and possibly other tissues [1]. These alternatives or
supplements to BAT-nonshivering thermogenesis (BAT-NST) remain to
be fully deﬁned and explored for application to the obesity problem.
Using themouse as amodel I would like to show that the association
of uncoupling protein 1 (UCP1) BAT-NST with reduction in obesity
depends highly on the environmental conditions of the study. Following
the 1979 Nature paper by Rothwell and Stock it was assumed that an
animal with reduced UCP1, as would occur in an Ucp1−/− mouse,
would be susceptible to genetic or diet-induced obesity [2]. However,
it was clear when the Ucp1 KOmouse was developed that this assump-
tionwas invalid. Mice deﬁcient in UCP1 do not have increased suscepti-
bility to obesity. To the contrary, at reduced ambient temperatures, for
example at 20 °C, Ucp1−/− mice are more resistant to DIO when fed
a high fat diet, but at thermoneutrality depending on the laboratory,
the level of DIO is the same as that observed in wild type mice [3,4] or
slightly higher in the Ucp1−/− mice [5,6]. The thermoneutral zone,
which is deﬁned as the ambient temperature at which the animal
is not required to activate thermoregulatory mechanisms to maintain
a normal body temperature, lies between 27 and 37 °C [7]. When
wild-type mice are moved from the thermoneutral zone to 4 °C they
show no evidence of increased cold sensitivity [8], which is to be
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diminished when mice are housed at thermoneutrality. Involution of
iBAT does not occur at thermoneutrality, possibly because it develops
precociously in utero and must be fully functional at birth [9,10].
At thermoneutrality the brown adipocytes in the interscapular fat
accumulate more fat, which forms larger lipid vesicle, but the level of
UCP1 and proteins of the respiratory complex is reduced less than 50%
(Gospodarska and Kozak, manuscript in preparation) indicating that
the tissue has the molecular machinery to be thermogenically active.
However, Ucp1−/− mice, maintained at thermoneutrality and then
transferred to 4 °C, are extremely sensitive to cold with body tempera-
ture dropping 10° within 1.5 h [8]. As illustrated in Fig. 1 Ucp1−/−
mice are very cold sensitive whether the genetic background is B6 or
129. Surprisingly, Ucp1−/− mice on the (B6x129) F1 background are
as resistant to the cold as wild-type mice. The reason for this molecular
heterosis has not been determined [11]. A critical feature of the change
in body temperature upon exposure to the cold as monitored in these
mice by telemetry, is that there is no lag indicative of an initial protection
of body temperature by shivering, which others have predicted [7],
but not observed in these experiments. Furthermore, wild type mice,
maintained at thermoneutrality, do not show an initial sensitivity to
the cold, which might be expected, if functional BAT was not initially
present when they were exposed to an ambient temperature of 4 °C.
The corollary to this phenotype is that shivering, which is commonly
believed to be the ﬁrst line of defense against the cold, is ineffective asFig. 1. Body temperature of mice during cold exposure. Mice maintained at 27 °C were
transferred to a 4 °C environment. Body temperatures were immediately monitored
continually using implanted probes and receiver units. A, 129/SvImJ and C57BL/6J
wild-type mice; B and C, UCP1-deﬁcient mice congenic on 129/SvImJ and C57BL/6J
backgrounds, respectively; D, UCP1-deﬁcient mice on a (129/SvImJ × C57BL/6J)/F1
hybrid background. Each tracing represent the body temperature if an individual mouse.a thermogenic system to protect body temperature upon acute exposure
to the cold. The inability of shivering to defend against the cold is also
observed for ob/ob, and db/dbmice [12] and a growing list of mice with
mutations to genes encoding enzymes of lipid metabolism [13–16].
However, as Skilling et al. point out the major factor causing cold
sensitivity in the Acads−/− mouse may not be reduced BAT function,
but cardiac function [16].
What emerges from effects of inactivation of Ucp1 on energy
balance and susceptibility toDIO is a picture of the adaptive biochemical
mechanisms utilized by the UCP1-deﬁcient mouse to maintain normal
body temperature. In the absence of an efﬁciently functioning thermo-
genic mechanism based upon UCP1 in BAT or in mice with inactivated
acyl-CoA dehydrogenases in BAT to support beta-oxidation of fatty
acids for respiration [13], maintenance of body temperature becomes
increasingly dependent on alternative thermogenic mechanisms. These
alternative mechanisms have the property that they are less efﬁcient
at regulating heat production; they lack the ﬁne tuning of activation
of thermogenesis by the sympathetic nervous activity to BAT; and the
rapid distribution of heat by the elaborate vascular system of BAT.
As the result they burn more fuel. The reduction in metabolic efﬁciency
when a mouse utilizes an alternative thermogenic mechanism is the
result of changes in the management of heat utilization and distribution
and does not imply a violation of basic thermodynamic principles as
stated by Cannon and Nedergaard [7]. It becomes apparent that thermo-
genesis for both body temperature and weight regulation is not a physi-
ological process utterly dependent on BAT-NST, rather it is dependent on
multiple complex systemic mechanisms.
A central problem in deﬁning mechanisms of NST is that we do not
have methods or biomarkers of thermogenesis that can quantify
the independent contributions of BAT and other peripheral tissues,
especially the putative role of shivering by skeletal muscle [7]. The
mere fact that a Ucp1−/− mouse is observed to shiver more than the
wild type control says nothing about whether or not shivering contrib-
utes signiﬁcantly to whole body thermogenesis [7]. In fact, we cannot
evaluate the contributions of brown adipocytes in the discrete brown
fat depots (iBAT) independent of brown adipocytes in white fat depots
(wBAT). The relative contribution of the different brown adipocyte
types may be important as implied by the beige nomenclature [17,18].
Beige refers to those brown adipocytes induced in white fat depots that
have a more brown color by immunohistology than those in iBAT. It is
unresolvedwhether those brown adipocytes induced inwhite fat depots
have less thermogenic capacity than the brown adipocytes located in the
discrete brown fat tissue derived from the muscle progenitor lineage.
Accordingly, despite the generation of over 24 transgenic and KOmodels
affecting the content of UCP1/BAT and which have been evaluated
for their contribution of BAT thermogenesis to the regulation of adiposity
[19], we cannot estimate the contribution fromBAT except in onemodel,
the Ucp1−/− mouse. Their resistance to DIO at ambient temperatures
below thermoneutrality indicates that the absence of UCP1 sets in
motion changes that have profound effects on the development of
systemic UCP1-independent mechanisms of thermogenesis when the
animal is challenged by the cold [4].
2. Evidence for the regulation of obesity by NST-BAT
A review of genetic models linking UCP1-BAT activity and adiposity
follows below.
2.1. The aP2-Ucp1 transgenic model
The ﬁrst genetic model showing that increased expression of UCP1
can reduce obesity was the aP2-Ucp1 transgenic mouse [20]. The
aP2 promoter in this transgene directed expression to both white
and brown adipocytes (and maybe macrophages as well [21]). Two
features of the aP2 promoter are critical in evaluating its use for
over-expression studies in adipose tissue. First, aP2 is expressed at
AB 
Ucp1+/+   5.6 g       828 kcal         0.68 
Ucp1-/-     2.7 g       807 kcal         0.33 
ΔB. Wt.  Food Intake   Met Efficiency 
Metabolic Efficiency at 20°C
Fig. 2. Diet-induced thermogenesis in the cold and at thermoneutrality. A. Reduced ambient
temperature suppressed the development of obesity in male 2-month-old Ucp1−/− mice
(open symbols) compared toUcp1+/+mice (ﬁlled symbols). B.When the ambient temper-
ature was increased to 27 °C (thermoneutrality) the similar rate of increase in adiposity
indicates that metabolic efﬁciency, whichwas 2 fold lower in Ucp1−/−mice, was no longer
different than that of Ucp1+/+mice. Signiﬁcance at P b 0.05 is indicated by (*).
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range of physiological concentrations of UCP1 in iBAT. Second, its
expression is constitutive. Unlike the Ucp1 or Pgc-1 genes which are
regulated in a pulsatile manner by the sympathetic nervous system
in response to changes in the ambient temperature (see discussion of
BAT activation by Cannon and Nedergaard in [22]), aP2 drives the
expression of linked genes at a constant high level. The consequence of
constitutive expression of the transgene is that the Ucp1 expression in
iBAT is derived almost exclusively from the transgenic aP2 promoter.
Accordingly, the requirements for iBAT thermogenesis to maintain
body temperature is satisﬁed by the transgene, but it is unregulated,
producing heat even when it is not required. This mechanism of heat
production is as unnatural as a constant administration of a beta-3
adrenergic agonist [23], but unlike a drug it cannot be stopped. Thermo-
genesis by constitutive over-expression of UCP1 escapes regulation
by the normal controls of thermogenesis by free fatty acids that activate
UCP1 or the buildup of nucleotides that inhibit UCP1 activity in the
mitochondria. Similar to the aP2-Ucp1 transgenic mouse, ectopic
expression of Ucp1 in skeletal muscle reduces adiposity and improves
insulin sensitivity, but at the cost of a profound reduction in muscle
mass, [24,25]. Accordingly, increased UCP1 ectopically expressed in
skeletal muscle must also escape the normal physiological regulatory
mechanisms that avoid energy stress.
The initial analysis of the aP2-Ucp1 transgenic mouse was made on
hemizygous animals; however, when the mouse was made homozy-
gous for the transgene, the unexpected ﬁnding was that interscapular
brown fat was over 95% ablated [26]. Accordingly, the high levels of
UCP1expression from the aP2 promoter were cytotoxic to the brown
adipocytes in iBAT. This is in contrast to the Ucp1-DTA transgenic
mouse; expression of the diphtheria toxin A chain (DTA) is cytotoxic
so that its presence in the brown adipocyte by the Ucp1 promoter was
expected to lead to iBAT ablation. This mouse, which had about 60%
of iBAT deleted, was tolerant to the cold and obese, presumably due to
a reduced capacity for thermogenesis, but actually from hyperphagia
[27–29]. The homozygous aP2-Ucp1 mouse, which was clearly much
more deﬁcient in its capacity for BAT thermogenesis than the Ucp1-DTA
mouse, was lean and resistant to diet-induced obesity and very sensi-
tive to the cold. As described below, the phenotype of the homozygous
aP2-Ucp1 transgenic mouse and the Ucp1−/− mice is remarkably
similar. The important lesson from the aP2-Ucp1 transgenic model of
Ucp1-BAT function is that a reduced capacity for UCP1-BAT thermo-
genesis in a mouse does not lead to increased obesity in a mouse room
maintained at 23 °C. Additionally, over-expression of UCP1 can severely
retard the development of tissues expressing the transgene.
2.2. The Ucp1−/− mouse model
The 1979 Nature paper by Rothwell and Stock proposed that
diet-induced thermogenesis was derived by the induction of Ucp1
in iBAT of rats fed a cafeteria diet [2]. They proposed a model by
which BAT thermogenesis was induced by a central mechanism
that responded to an increased positive energy balance. This model
predicted that inactivation of Ucp1 by gene targeting would reduce
the capacity for BAT thermogenesis and mice fed a high fat diet would
be more susceptible to obesity [30]. Unexpectedly, Ucp1−/− mice
were resistant to obesity when fed a high fat diet even at a normal
ambient temperature of 23 °C [31]. As illustrated in independent exper-
iments in Fig. 2, themetabolic efﬁciency ofUcp1−/−mice fed a high fat
diet at 20 °C is 50% lower than that of wild type mice; however, when
the temperature is raised to the thermoneutral zone (28 °C) the differ-
ence in metabolic efﬁciency is lost as indicated by the identical rate of
increase in adiposity forUcp1−/− andwild-typemice. This experiment
indicated that mice have an alternative mechanism of thermogenesis
for the regulation of body temperature in the absence of UCP1 [3].
Five years later this experiment was repeated and provided essentially
identical results (Fig. 3), that is, the rate of fat mass gain at 20 °C was2 times higher in wild type mice than for Ucp1−/− mice (0.56 vs
0.30 g/week), but no differences (1.2 vs 1.24 g/week) when the ambient
temperature was increased to the thermoneutral zone (28 °C) [4]. The
energy metabolism phenotype of the Ucp1−/− mouse is completely
predicted from the seminal work of Ma and Foster who compared diet
induced thermogenesis in rats fed a cafeteria diet to rats fed a standard
low fat chow diet. By simultaneously monitoring blood ﬂow and oxygen
consumption through iBAT they showed that thermogenesis by iBAT
was strongly induced during cold exposure, but not induced by a cafete-
ria diet [32,33]. Since their study also showed an increase in whole body
thermogenesis in rats fed a cafeteria diet, it is clear that diet-induced
thermogenesis is real, but this diet-induced thermogenesis does not
signiﬁcantly involve BAT. These combined studies of diet-induced
thermogenesis in normal rats and in Ucp1−/− mice by indirect
calorimetry and energy balance studies strongly support the idea
that diet-induced thermogenesis can affect the development of
obesity; however, iBAT is not the dominant site of diet-induced
thermogenesis in either the rat or the mouse at 24 °C or 28 °C
(thermoneutrality). Increasing evidence suggests a role for skeletal
muscle in diet-induced thermogenesis [34].
Other studies reported that Ucp1−/− mice fed a high fat diet at
thermoneutrality are more obese thanwild-typemice in an obesogenic
environment. The authors proposed that this increased susceptibility
to obesity was due to reduced diet-induced thermogenesis from the
absence of UCP1 in Ucp1−/− mice [5]. The key element emphasized
in this study was that the difference in adiposity depended upon
a thermoneutral environment [5]. Similar results have shown that
aging Ucp1−/− mice fed a high fat diet became more obese than
wild-type mice at about 5 months of age [6]. However, the authors
in this study concluded that the increase in adrenergically stimulated
lipolysis in brown and white fat depots, which was suppressed in
Ucp1−/−mice, could account for the differences in obesity. It has also
been proposed that the increased diet-induced obesity in mice carrying
a KO of the type 2 deiodinase gene are due to compensatory increases
in sympathetic activation [35].
AB
Rate of Fat Mass gain  
Fig. 3. Comparison of the rate of fat mass gain among wild-type, Ucp1−/− and Gdm−/−mice. A. Fat mass was determined by NMR. The data represents the means ± S.E.; n = 8.
The following symbols indicate no signiﬁcant differences between groups: *, WT versus Ucp1−/−. B. Calculation of the rates of fat mass gain. a, b, and c indicate means that are
statistically signiﬁcant at P b 0.05.
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the same original stock [3]; the differences in rearing conditions
among the labs, particularly during early development when the
Ucp1−/− mice are most sensitive to the cold environment, could
render differences in long term responses to an obesogenic diet.
If diet-induced obesity at thermoneutrality is greater in Ucp1−/−
than in wild type mice in studies from some laboratories, but not in
others, and these studies are conducted with the same line of mutant
mice, then the differences are probably not a function of Ucp1−/− ,
but some other conditions of the experiment. These conditions remain
to be established.3. Transgenic models of cellular signaling shift the focus to brown
adipocytes in traditional white fat depots
Interest in enhancing the content of brown adipose tissue to reduce
obesity, either genetic or environmental, has led to the development of
transgenic micewith altered signaling activity that drives the induction
of brown adipose activity. The ﬁrst such transgene was the aP2-β1
adrenergic receptor, which reduced obesity and insulin resistance,
increased the content of brown adipocytes in white fat depots as
evidenced histologically and by Ucp1 mRNA levels, but showed no
increase of Ucp1 mRNA in iBAT [36]. Given that the β1 adrenergic
receptor was over-expressed in all white fat depots examined
and that isolated adipocytes from white fat depots of transgenic
mice had increased lipolysis following catecholamine stimulation,
it is uncertain whether the reduced adiposity came from increasedBAT activity or lipolysis followed by increased fatty acid oxidation
systemically.
Since this initial paper on the effects of altered signaling on
energy balance phenotypes, many other transgenic or KO models
that modulate UCP1 up or down have been produced that affect
obesity phenotypes. Almost invariably the obesity phenotype,
including effects on oxygen consumption, has been attributed to a
modest change in Ucp1 expression in either white fat or brown fat.
Many of these conclusions, implicating UCP1 and BAT as the under-
lying mechanism for the energy balance phenotype, are unjustiﬁed
[37]. It is essential to view such conclusions with the knowledge that
the complete absence of UCP1 in mice, maintained at an ambient tem-
perature of 24°, does not produce obesity nor reduce oxygen consump-
tion asmeasured by indirect calorimetry. Anymanipulation of a gene or
cell that results in a change in body composition or energy expenditure
and is attributed to a modest reduction or induction in iBAT should
be routinely evaluated to assess the effects of non-BAT tissues to the
obesity phenotype. While it may not be possible to evaluate directly
the contribution of other tissues because of a lack of biomarkers, it
is possible to analyze the phenotype on the Ucp1−/− genetic back-
ground. For example, if the effects on energy balance and oxygen
consumption continue to be expressed when a selective neuron in the
hypothalamus of aUcp1−/−mouse has been deleted or has a signaling
pathway inactivated, then it is probable that the energy balance pheno-
type may be real, but it is not caused by a modest change in Ucp1
expression in iBAT. It is conceivable that the Ucp1−/− mouse has
somemetabolic or morphological abnormalities, caused by the absence
of UCP1 by some unknown mechanism. For example, what are the
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that is a part of the Ucp1−/− phenotypemice at ambient temperatures
below thermoneutrality [3]. Breeding performance, fertility, body
composition and life span are normal under standard laboratory
conditions [3–6].
3.1. Natural allelic variation in wBAT expression occurs in inbred strains
of mice. Is this also the basis of the high variability observed in humans
by PET imaging?
Brown fat ﬁrst appears in the interscapular region as a discrete
tissue in the late fetal and newborn mouse and these discrete collec-
tions of cells are maintained at a rather constant level, independent of
environmental conditions, for the lifespan of the mouse [10–38]. A
second type of brown adipocytes appears transiently between 10 and
35 days of age at normal ambient temperature, but they can remerge
in a diffusemanner inwhite fat depots depending on the environmental
conditions, especially the cold environment, and on allelic variation
present in inbred mouse strains [39]. The brown adipocytes induced
in white fat (wBAT) are highly variable compared to the iBAT expres-
sion. In addition to developmental age, expression also varies among
the differentwhite fat depots and depends on the ambient temperature,
being almost undetectable at 23 °C to the levels of Ucp1 mRNA that
increase up to 100-fold at 4 °C [40]. Similar variability, based upon
environmental conditions, also exists in human BAT expression [41].
Therefore, if the level of expression of wBAT inﬂuences the course of
environmental or genetic obesity it would be important to determine
whether genetically determined variability of BAT also exists in humans.
Perhaps as much as any other environmental condition such variability
in BAT expression could have an impact on capacity for thermogenesis
and the regulation of body weight.
We have a framework of the developmental proﬁle of brown
adipocyte in the mouse; however, a similar framework is lacking
in the human. PET analysis has shown focal concentrations of radio-
active 18FDG uptake in the scapular region, the base of the neck and
along the upper spinal cord. Histological analyses shows a tissue
morphology for these deposits of brown adipocytes in humans as
being more akin to the diffuse brown fat depots of mice in which
multi-locular, UCP1-positive adipocytes are interspersed with
unilocular adipocytes, which increases in proportion to the level of
obesity. In contrast, iBAT tissue is composed of a homogeneous
ﬁeld of cells packed with mitochondria and small lipid droplets,
with the latter varying in size in proportion to BAT activity. The
physiological function of BAT in humans remains to be determined.
Correlative studies indicate that PET-BAT in humans shows more
intense images in the young than the old, females thanmales, in winter
than in summer and in obese subjects the images are less intense than
in lean subjects [42–45]. Since cold exposure by immersing a hand
or foot in an ice bath or adrenergic stimulation by treatment with a
beta-adrenergic agonist stimulates a PET image, it is possible that the
variation in UCP-BAT largely reﬂects the effects of the cold environ-
ment. PET-BAT images in humans are less intense in obese individuals;
this has been interpreted as a reduced level of BAT thermogenesis in
obese subjects [46]. However, it has recently been pointed out that the
low average density of humans BAT depots may reﬂect the relatively
low density of brown adipocytes in obese subjects [47]. The higher
dispersion of BAT cells in the obese subjects, which is outside the
resolving power of PET imaging, may lead to an under estimate of the
number of brown adipocytes in the tissue of obese individuals.
3.2. Genetics and the variation in UCP1 expression
Given that quantiﬁcation of the high variability of thermogenically
active BAT in humans is problematic, it is tempting to speculate that
allelic variation may contribute to BAT function. At this time there
has been no estimate of the contribution of genetics to the variationin BAT among humans. A key question to be addressed is whether var-
iation in BAT of humans is genetically determined andwhether it affects
their obesity phenotype. There could be a genetically determined varia-
tion in adrenergically inducible Ucp1/BAT or alternatively, a variation in
Ucp1 expression among humans at thermoneutrality, that is, a mecha-
nism related to induction of Ucp1 by dietary conditions. The high varia-
tion in BAT found among inbred strains of mice is associated with cold
or adrenergically stimulated BAT production in traditional white
adipose tissues, but not in iBAT depots. Detection of signiﬁcant levels
of BAT in white fat mice occurs in mice that have been exposed to the
cold or treated with CL316,243 (β3-adrenergic receptor agonist) [40].
Several quantitative trait loci that control the induction ofUcp1 in retro-
peritoneal fat depot by cold have been genetically mapped to in the
mouse.While the presence of a high fat diet inﬂuenced the contribution
of different QTLs, the overall increase in expression in segregating mice
fed a high fat die was verymodest [48]. With respect to the role of Ucp1
expression in diet-induced thermogenesis and susceptibility to obesity
in a state of positive energy balance, variation in the level of UCP1 at
thermoneutrality fed a low or high fat diet is a critical issue that has
not been analyzed genetically. Accordingly, the variation in both mice
and humans occurs in those brown adipocytes that are induced and
reside white fat depots. Since strong evidence exists showing that the
variation in Ucp1 expression in mice is genetically controlled in selective
white fat depots [49], an obvious question is whether there is a genetic
component to BAT variation in humans.
The natural variation in Ucp1 expression that occurs among inbred
strains ofmice provides amodel to explore the relationship between in-
duction ofUcp1 and resistance to both genetic and diet-induced obesity.
High levels of UCP1/BAT can be induced in selective white fat depots of
A/J and 129 mice by exposing mice to the cold, whereas, B6 mice are
much less inducible. The genetics of this variation in Ucp1 induction is
complex, since it is caused by variant alleles at several unlinked genes.
Recombination of A/J and B6 alleles in recombinant inbred strains of
mice has shown that epistasis exists in the control of Ucp1/BAT induc-
tion, that is, recombination leads to inbred mice that have levels of
expression that are quantitatively beyond the maximum range of
Ucp1 expression present in A/J or B6 parental mice [40–49]. Twenty-
six independent lines of AXB (A/J × B6) recombinant mice have levels
of inducible Ucp1 mRNA that vary 132 fold in a continuum [40].
If these mice are made obese with a high fat diet and then treated
with a β3-adrenergic receptor agonist (CL-316,243), those mice with
the highest induction of Ucp1 in white fat depots have a greater reduc-
tion of obesity [40]. This was a key experiment that shows a strong
association between the capacity for induction of Ucp1/BAT in white
fat and reduction of obesity, but only when accompanied by adrenergic
stimulation. Variation in Ucp1 induction without sympathetic stimula-
tion has not been studied to our knowledge. Whether a high fat diet
per se induces Ucp1 is unresolved as reported by a recent review of
the topic [50]. The general conclusion from this comprehensive review
of the literature suggests that induction of Ucp1 by a high fat diet is
observed in iBAT, but not in brown adipocytes in white fat depots.
Therefore, it is not possible to induce UCP1 and correspondingly
diet-induced thermogenesis in WAT by an obesogenic diet. High levels
of UCP1 inwhite fat depots ofmice occurwhen the adrenergic signaling
to the tissue is activated by cold exposure [40], or possibly in an
enriched physical environment [51] or signaling to WAT by the natri-
uretic peptide [52]. However, the latter 2 protocols have not been eval-
uated with the Ucp1−/− mouse. Determining the role of the genetic
background will be a major hurdle towards understanding the effects
of the environment in conjunction with the inﬂuence of developmental
age on the capacity for thermogenesis in humans.
4. Summary
The focus of this review has been on the production of heat in
response to the cold environment. As depicted in the model of Fig. 4
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When Ucp1−/− mice are exposed to a cold environment an increase
in adrenergic signaling is sent to brown adipose tissue to compensate
for reduced capacity for thermogenesis to maintain body temperature.
This attempt to generate heat from BAT is unproductive; however,
an increase in sympathetic activity is effective when directed to
other alternative sites of thermogenesis. Enhanced signaling to WAT
of Ucp1−/−mice attempts to compensate by increasing the differenti-
ation of brown adipocytes, but these brown adipocytes are also ineffec-
tive in producing heat. There is, however, an increase in adrenergic
stimulated lipolysis to provide fuel to support thermogenesis from
alternative sites of thermogenesis. As discussed recently, alternative
thermogenic mechanisms seem to be principally proteins involved in
Ca++ cycling in skeletal muscle, including sarcolipin, ATP-Mg++/Pi
Transporter (Slc25a25) and the mitochondrial glycerol 3-phosphate
dehydrogenase. Perhaps the major contribution of the Ucp1−/−mouse
is that it has provided amodel system to discover alternative thermogenic
mechanisms. The keystone of this argument is that the Ucp1−/−mouse
is resistant to diet-induced obesity at reduced ambient temperatures.
It follows therefore that multiple alternative thermogenic mechanisms
must be recruited to protect the mouse from the cold at a greater caloric
cost. In a population of normal individuals, that is, those carrying a normal
wild typeUcp1 gene the contribution of BAT relative to other thermogenic
mechanisms will vary among individuals, but basic thermodynamic
principles indicate that the cold environmentwill increase energy expen-
diture. One can even make a case for blocking UCP/BAT thermogenesis
and other thermogenic mechanisms to reduce metabolic efﬁciency as
an anti-obesity strategy. From this perspective models based on UCP1/
BAT as amechanism for reducing obesity in a thermoneutral environment
have little relevance, unless you seek to develop drugs for the population
living at thermoneutrality. In any case the mechanism for increased
obesity at thermoneutrality in the absence of UCP1 is still unknown.
It may have nothing to do with diet-induced thermogenesis by a high
fat diet; however, we can be certain that like physical activity cold-
stimulated thermogenesis will effectively stimulate energy expenditureCold environment 5°C
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Fig. 4. A model that illustrates the quantitative contribution of major thermogenic
pathways in Ucp1+/+ and Ucp1−/− mice. The numbers in red reﬂect: the strength of
the adrenergic signaling from the hypothalamus to adipose tissue and tissues of alternative
thermogenesis. The strength of the corresponding thermogenic response from brown
adipose tissue and tissues, which are alternative sources of thermogenesis, are indicated
and as well as lipolysis in WAT to supply fatty acids for β-oxidation. The experimental
basis for these estimates is the evidence that higher levels of type 2 deodinase, and
brown adipocytes are found in inguinal fat of Ucp1−/− mice as they attempt to increase
thermogenesis. Ucp1−/− mice have increased expression of Slc25a25 and other genes
involved in skeletal muscle and their reduced adiposity indicates increased utilization of
adipose stores dependent on increase adrenergic signaling.and reduce obesity. Well-designed studies with animal models can
provide the base of knowledge to establish conditions, particularly in
children, thatwill support a strategy of lowering the ambient temperature
of the home, school and work place to combat obesity.
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